Literature DB >> 7618010

Anabolic-androgenic steroids. Current issues.

C E Yesalis1, M S Bahrke.   

Abstract

The use of drugs to enhance physical performance has been observed for thousands of years. Today, individuals continue to use a variety of substances, including anabolic-androgenic steroids, in the hope of enhancing their performance and appearance. Rumours persist regarding the incidence of the nonmedical use of anabolic steroids by athletes and nonathletes: however, true estimates are now available based on the results of systematic surveys. Although the vast majority of the athletic community accepts that anabolic steroids enhance performance and appearance, the extent to which this occurs and the factors influencing such effects remain incompletely understood and documented. Refinement of our knowledge of the ergogenic effects of anabolic steroids is not without merit; however, the existing scientific evidence coupled with an overwhelming number of anecdotal accounts argues against devoting significant resources to this area of investigation at present. The short term health effects of anabolic steroids have been increasingly studied and reviewed, and while anabolic steroid use has been associated with several adverse and even fatal effects, the incidence of serious effects thus far reported has been extremely low. The long term effects of anabolic steroid use are generally unknown. Unfortunately, the lack of scientific information on long term health effects has impeded, if not precluded, the formation of effective health education and drug abuse prevention strategies. Consequently, efforts should be expanded in the areas of prevention and education.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7618010     DOI: 10.2165/00007256-199519050-00003

Source DB:  PubMed          Journal:  Sports Med        ISSN: 0112-1642            Impact factor:   11.136


  60 in total

1.  Anabolic steroid-induced hypogonadotropic hypogonadism.

Authors:  J P Jarow; L I Lipshultz
Journal:  Am J Sports Med       Date:  1990 Jul-Aug       Impact factor: 6.202

2.  Anabolic steroid dependence.

Authors:  L R Hays; S Littleton; V Stillner
Journal:  Am J Psychiatry       Date:  1990-01       Impact factor: 18.112

3.  Drug testing at the 10th Asian Games and 24th Seoul Olympic Games.

Authors:  J Park; S Park; D Lho; H P Choo; B Chung; C Yoon; H Min; M J Choi
Journal:  J Anal Toxicol       Date:  1990 Mar-Apr       Impact factor: 3.367

4.  Anabolic-androgenic steroid dependence.

Authors:  K J Brower; F C Blow; T P Beresford; C Fuelling
Journal:  J Clin Psychiatry       Date:  1989-01       Impact factor: 4.384

5.  Anabolic steroid dependence with opioid-type features.

Authors:  F Tennant; D L Black; R O Voy
Journal:  N Engl J Med       Date:  1988-09-01       Impact factor: 91.245

6.  Despite warnings, lure of steroids too strong for some young Canadians.

Authors:  S Newman
Journal:  CMAJ       Date:  1994-09-15       Impact factor: 8.262

7.  AIDS in a bodybuilder using anabolic steroids.

Authors:  H M Sklarek; R P Mantovani; E Erens; D Heisler; M S Niederman; A M Fein
Journal:  N Engl J Med       Date:  1984-12-27       Impact factor: 91.245

Review 8.  Atherogenic effects of anabolic steroids on serum lipid levels. A literature review.

Authors:  G Glazer
Journal:  Arch Intern Med       Date:  1991-10

9.  Coagulation abnormalities associated with the use of anabolic steroids.

Authors:  J E Ansell; C Tiarks; V K Fairchild
Journal:  Am Heart J       Date:  1993-02       Impact factor: 4.749

10.  Anabolic steroid use among students at a British college of technology.

Authors:  D J Williamson
Journal:  Br J Sports Med       Date:  1993-09       Impact factor: 13.800

View more
  22 in total

Review 1.  Risk factors associated with anabolic-androgenic steroid use among adolescents.

Authors:  M S Bahrke; C E Yesalis; A N Kopstein; J A Stephens
Journal:  Sports Med       Date:  2000-06       Impact factor: 11.136

2.  Some rewarding effects of androgens may be mediated by actions of its 5alpha-reduced metabolite 3alpha-androstanediol.

Authors:  Cheryl A Frye
Journal:  Pharmacol Biochem Behav       Date:  2006-11-15       Impact factor: 3.533

Review 3.  The placebo effect in sports performance: a brief review.

Authors:  Christopher J Beedie; Abigail J Foad
Journal:  Sports Med       Date:  2009       Impact factor: 11.136

Review 4.  Drugs and sport. Research findings and limitations.

Authors:  P M Clarkson; H S Thompson
Journal:  Sports Med       Date:  1997-12       Impact factor: 11.136

Review 5.  Prevalence of doping use in elite sports: a review of numbers and methods.

Authors:  Olivier de Hon; Harm Kuipers; Maarten van Bottenburg
Journal:  Sports Med       Date:  2015-01       Impact factor: 11.136

Review 6.  Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement.

Authors:  Harrison G Pope; Ruth I Wood; Alan Rogol; Fred Nyberg; Larry Bowers; Shalender Bhasin
Journal:  Endocr Rev       Date:  2013-12-17       Impact factor: 19.871

7.  Biochemical and oxidative stress markers in the liver and kidneys of rats submitted to different protocols of anabolic steroids.

Authors:  Guilherme Lopes Dornelles; Andressa Bueno; Juliana Sorraila de Oliveira; Aleksandro Schafer da Silva; Raqueli Teresinha França; Cássia Bagolin da Silva; Márcia Silveira Netto Machado; Letícia do Santos Petry; Fátima Husein Abdalla; Cibele Lima Lhamas; Cinthia Melazzo de Andrade
Journal:  Mol Cell Biochem       Date:  2016-11-28       Impact factor: 3.396

8.  Anabolic-androgenic steroid use among high school football players.

Authors:  V G Stilger; C E Yesalis
Journal:  J Community Health       Date:  1999-04

Review 9.  Psychological and behavioural effects of endogenous testosterone and anabolic-androgenic steroids. An update.

Authors:  M S Bahrke; C E Yesalis; J E Wright
Journal:  Sports Med       Date:  1996-12       Impact factor: 11.136

Review 10.  Factors Influencing Clinical Correlates of Chronic Traumatic Encephalopathy (CTE): a Review.

Authors:  Breton M Asken; Molly J Sullan; Aliyah R Snyder; Zachary M Houck; Vaughn E Bryant; Loren P Hizel; Molly E McLaren; Duane E Dede; Michael S Jaffee; Steven T DeKosky; Russell M Bauer
Journal:  Neuropsychol Rev       Date:  2016-08-25       Impact factor: 7.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.